Tue 11/01/2022 09:47 AM
Global oncology services provider GenesisCare’s net leverage reached 40x at the end of September after earnings continued their downward trajectory. According to the group’s covenant compliance certificates, LTM consolidated EBITDA fell to just $35.6 million by the end of September from $60.5 million at the end of June and $91.6 million at the end of March, sources said.
GenesisCare generated $1.466 billion of revenue in the year to June, a marginal increase from $1.445 billion in fiscal...
This article is an example of the content you may receive if you subscribe to a product of Reorg Research, Inc. or one of its affiliates (collectively, “Reorg”). The information contained herein should not be construed as legal, investment, accounting or other professional services advice on any subject. Reorg, its affiliates, officers, directors, partners and employees expressly disclaim all liability in respect to actions taken or not taken based on any or all the contents of this publication. Copyright © 2024 Reorg Research, Inc. All rights reserved.